ARCHIVES

SAIC Frederick Offers Use Of Drug Facility

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Feral Mouse Colony Recompetition Given Concept Approval

November 16, 1990

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975

NCI Seeks Health Care Provider Groups To Form Cancer Control Research Network

September 12, 1997